Category: Articles | Page 9

Moving beyond risk-based testing: Checklist for supporting hepatitis C birth cohort screening

July 19, 2021 • By Dr. Sofia Bartlett, Stephanie Gin and Dr. Terri Buller-Taylor

British Columbia is the first province or territory in Canada to recommend one-time birth cohort screening for hepatitis C among people born from 1945 to 1965. This birth cohort has been identified as a key population that needs to be engaged into hepatitis C virus (HCV) care to reduce liver disease complications for several reasons: there are many undiagnosed cases of hepatitis C, they account for nearly 60% of positive hepatitis C results in B.C., and many people in this cohort have not received confirmatory HCV RNA testing.

Talking about hepatitis C with immigrants and newcomers to Canada

July 7, 2021 • By Fozia Tanveer

In Canada, one in three people affected by hepatitis C was born outside of the country. Hepatitis C prevalence among Canadian immigrants and newcomers is double the overall Canadian prevalence. Research also shows that immigrants and newcomers experience worse health outcomes from viral hepatitis and liver cancer when compared to the Canadian-born population, including higher rates of hepatocellular carcinoma and mortality rates from viral hepatitis and liver cancer that are two to four times higher. Talking to Canadian immigrants about hepatitis C becomes very important given the fact that they are a population at risk of disease.

Holding governments accountable: Canada’s progress on viral hepatitis elimination

July 7, 2021 • By Jennifer van Gennip

In May 2021, Action Hepatitis Canada (AHC) released its Progress Toward Viral Hepatitis Elimination in Canada 2021 Report. Five years earlier, in May 2016, Canada had signed on to the World Health Organization’s (WHO) first-ever Global Viral Hepatitis Strategy with the goal of eliminating viral hepatitis as a public health threat by 2030. With both a cure for hepatitis C (HCV) and a vaccine for hepatitis B (HBV), this seemed to be a very realistic goal within a reasonable timeframe. But five years on, we had important questions about how Canada was really doing as time was ticking on.

Improving HIV testing and care in Canada: I’m Ready and Sex Now – Test@Home

June 27, 2021 • By Dr. Sean B. Rourke and Prof. Nathan Lachowsky

HIV self-testing was approved in Canada in November 2020, largely thanks to research conducted by REACH Nexus, part of Unity Health Toronto’s Map Centre for Urban Health Solutions. But approval does not mean access – the next step is getting self-tests into the hands of people who don’t know they have HIV, and linking them to follow-up treatment and care.

In the U=U era, how do we talk about the prevention benefits of HIV treatment beyond sex?

April 28, 2021 • By Mallory Harrigan

While the U=U message has been getting a lot of momentum in recent years, the role of HIV treatment in preventing HIV through other transmission routes is not as widely known. This information is important for informed healthcare decision making and further destigmatizing HIV.

From hesitance to confidence: ACCHO’s new COVID-19 vaccine video

April 22, 2021 • By Wanjiru Munene and Ikran Ibrahim

The African and Caribbean Council on HIV/AIDS in Ontario (ACCHO) is a provincial coalition of organizations and individuals committed to HIV prevention, education, advocacy, research, treatment, care and support for African, Caribbean and Black (ACB) communities. They spoke to CATIE about the impact of COVID-19 in ACB communities, and their efforts to improve vaccine confidence.